Commission Implementing Regulation (EU) No 160/2013 of 21 February 2013 amending Regulations (EC) No 162/2003, (EC) No 971/2008, (EU) No 1118/2010 and (EU) No 169/2011 and Implementing Regulation (EU) No 888/2011 as regards the name of the holder of the authorisation of diclazuril in animal feed Text with EEA relevance
Modified by
Commission Implementing Regulation (EU) No 667/2013of 12 July 2013concerning the authorisation of diclazuril as a feed additive for chickens reared for laying (holder of authorisation Eli Lilly and Company Ltd) and repealing Regulation (EC) No 162/2003(Text with EEA relevance), 32013R0667, July 13, 2013
Commission Implementing Regulation (EU) No 160/2013of 21 February 2013amending Regulations (EC) No 162/2003, (EC) No 971/2008, (EU) No 1118/2010 and (EU) No 169/2011 and Implementing Regulation (EU) No 888/2011 as regards the name of the holder of the authorisation of diclazuril in animal feed(Text with EEA relevance)Article 1Amendment to Regulation (EC) No 162/2003In column 2 of the Annex to Regulation (EC) No 162/2003 the words "Janssen Pharmaceutica NV" are replaced by "Eli Lilly and Company Ltd".Article 2Amendment to Regulation (EC) No 971/2008In column 2 of the Annex to Regulation (EC) No 971/2008 the words "Janssen Pharmaceutica nv" are replaced by "Eli Lilly and Company Ltd".Article 3Amendment to Regulation (EU) No 1118/2010In column 2 of the Annex to Regulation (EU) No 1118/2010 the words "Janssen Pharmaceutica NV" are replaced by "Eli Lilly and Company Ltd".Article 4Amendment to Regulation (EU) No 169/2011In column 2 of the Annex to Regulation (EU) No 169/2011 the words "Janssen Pharmaceutica N.V." are replaced by "Eli Lilly and Company Ltd".Article 5Amendment to Implementing Regulation (EU) No 888/2011In column 2 of the Annex to Implementing Regulation (EU) No 888/2011 the words "Janssen Pharmaceutica N.V." are replaced by "Eli Lilly and Company Ltd".Article 6Transitional measureExisting stocks of this additive which are in conformity with the provisions applying before the date of entry into force of this Regulation may continue to be placed on the market and used until they are exhausted.Article 7Entry into forceThis Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.This Regulation shall be binding in its entirety and directly applicable in all Member States.
Article 1Amendment to Regulation (EC) No 162/2003In column 2 of the Annex to Regulation (EC) No 162/2003 the words "Janssen Pharmaceutica NV" are replaced by "Eli Lilly and Company Ltd".Article 2Amendment to Regulation (EC) No 971/2008In column 2 of the Annex to Regulation (EC) No 971/2008 the words "Janssen Pharmaceutica nv" are replaced by "Eli Lilly and Company Ltd".Article 3Amendment to Regulation (EU) No 1118/2010In column 2 of the Annex to Regulation (EU) No 1118/2010 the words "Janssen Pharmaceutica NV" are replaced by "Eli Lilly and Company Ltd".Article 4Amendment to Regulation (EU) No 169/2011In column 2 of the Annex to Regulation (EU) No 169/2011 the words "Janssen Pharmaceutica N.V." are replaced by "Eli Lilly and Company Ltd".Article 5Amendment to Implementing Regulation (EU) No 888/2011In column 2 of the Annex to Implementing Regulation (EU) No 888/2011 the words "Janssen Pharmaceutica N.V." are replaced by "Eli Lilly and Company Ltd".Article 6Transitional measureExisting stocks of this additive which are in conformity with the provisions applying before the date of entry into force of this Regulation may continue to be placed on the market and used until they are exhausted.Article 7Entry into forceThis Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.This Regulation shall be binding in its entirety and directly applicable in all Member States.